3STREWLER G, ROSENBLATT M. Etopic hormone production [ M ]//FELIG P. Endocrinology and metabolism. New York: McGraw-Hill, 1995:1405 - 1516.
4BAB I, GAVISH H. Isolation of mitogenically active C-terminal truncated pentapeptide of OGP from human plasma and culture medium of murine osteoblastic cells[ J]. J Pept Res, 1999, 54 (5) :408 -414.
5BRAGER MA, PATTERSON M J, CONNLLY JF. OGP normally stimulated by blood and marrow ablation has local and systemic effects on fracture healing in rats[J]. J Orthop Res, 2000, 18 (1) :133 -139.
6LUCAS TS, BAB I, LIAN JB. Stimulation of systemic bone formation induced by experimental blood loss [ J ]. Clin Orthop, 1997, (340) :267 -275.
7FAZZI R, GALIMBERTI S, TESTI R. Bone and bone marrow interactions: hematological activity of OGP-derived C-terminal pentapeptide [ J ]. Leuk Res, 2002, 26 (9) : 839 - 848.
8GUREVITCH O, SLAVIN S,MUHLRAD A. OGP increases blood and bone marrow cellularity and enhances engraftment of bone marrow transplants in mice[ J]. Blood, 1996, 88 (12) :4719 - 4724.
9FAZZI R, TESTI R, TRASCIATTI S. Bone and bone marrow interactions : hematological activity of OGP-5 : mobilizing properties of WBC and peripheral blood stem cells in mice [ J ]. Leuk Res, 2002, 26(1) :19 -27.
10BAB I, CHOREW M. Osteogenic growth peptide: from concept to drug design[J]. Biopolymers(Pept Sci), 2002, 66( 1 ) :33 - 48.
